Concepedia

Annie-Claire Diserens

AD

Statistics

Publications

3

Citations

1.6K

H-Index

3

Active since

2004

Affiliations

University of Lausanne(Current)

University Hospital of Geneva

Annie-Claire Diserens is an author at University of Lausanne specializing in glioblastoma, medicine, and cancer epigenetics.

Publications per year

2004–2012

3

Publications

3

Clinical Trial Substantiates the Predictive Value of <b> <i>O-6-Methylguanine-DNA Methyltransferase</i> </b> Promoter Methylation in Glioblastoma Patients Treated with Temozolomide

Monika E. Hegi, Annie-Claire Diserens, Sophie Godard et al. · Clinical Cancer Research · 2004 · 791 citations

Medicine, Molecular Genetics, Radiation Oncology +17

Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma

Roger Stupp, Monika E. Hegi, Bart Neyns et al. · Journal of Clinical Oncology · 2010 · 443 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status

Pierre Bady, Davide Sciuscio, Annie-Claire Diserens et al. · Acta Neuropathologica · 2012 · 359 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–3 of 3